Boundless Bio Inc. (BOLD) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Boundless Bio Inc.

    NASDAQ: BOLD · Real-Time Price · USD
    1.23
    0.02 (1.65%)
    At close: Oct 03, 2025, 3:59 PM
    1.26
    2.44%
    Pre-market: Oct 06, 2025, 07:10 AM EDT

    Boundless Bio Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -65.36M -49.43M -45.9M -25.21M
    Depreciation & Amortization
    		 1.09M 957K 942K 682K
    Stock-Based Compensation
    		 7.52M 3.34M 2.29M 1.16M
    Other Working Capital
    		 -2.45M -2.46M -1.04M -2.06M
    Other Non-Cash Items
    		 -2.4M 2.38M 1.7M 423K
    Deferred Income Tax
    		 n/a -3.3M 503K 536K
    Change in Working Capital
    		 -1.68M -799K 866K -837K
    Operating Cash Flow
    		 -60.84M -46.85M -39.6M -23.25M
    Capital Expenditures
    		 -2.54M -633K -1.07M -2.03M
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 -208.47M -160.12M -42.6M -77.49M
    Sales Maturities Of Investments
    		 184.9M 122.5M 59.8M 20.24M
    Other Investing Acitivies
    		 n/a n/a n/a n/a
    Investing Cash Flow
    		 -26.1M -38.26M 16.13M -59.28M
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -3.18M -1.77M 126K 208K
    Financial Cash Flow
    		 89.82M 97.9M 126K 105.53M
    Net Cash Flow
    		 2.88M 12.78M -23.34M 22.99M
    Free Cash Flow
    		 -63.38M -47.49M -40.66M -25.28M

    Add to Watchlist